The Valley Desk

NCT02482168 · Interventional trial

Study of the CD40 Agonistic Monoclonal Antibody APX005M

Overall registry status Completed

Phase 1

Conditions Cancer, Head and Neck Cancer, MSI-H, Melanoma, NSCLC, Urothelial Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov